X0508 4 2023-12-28 0 0001601830 RECURSION PHARMACEUTICALS, INC. RXRX 0001856414 Larson Tina Marriott 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101 0 1 0 0 President and COO 1 Class A Common Stock 2023-12-28 4 M 0 8000 1.06 A 422548 D Class A Common Stock 2023-12-28 4 S 0 8000 10.5817 D 414548 D Stock Option (Right to Buy) 8.55 2033-02-01 Class A Common Stock 0 434122 D Stock Option (Right to Buy) 1.06 2023-12-28 4 M 0 8000 0.00 D 2028-07-22 Class A Common Stock 8000 512000 D Stock Option (Right to Buy) 11.40 2032-02-04 Class A Common Stock 0 159226 D Stock Option (Right to Buy) 11.40 2022-02-04 2032-02-04 Class A Common Stock 0 4784 D Stock Option (Right to Buy) 2.48 2030-12-30 Class A Common Stock 0 150000 D Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023. Includes 1,144 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on November 20, 2023. The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $10.34 to $10.75 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. One forty-eighth (1/48th) of the shares subject to the award shall vest one month after December 31, 2020, or the Monthly Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Monthly Vesting Commencement Date. /s/ Jonathan Golightly, attorney-in-fact 2024-01-02